The US Food and Drug Administration (FDA) has approved diclofenac sodium injection (Dyloject, Hospira Inc), a proprietary nonsteroidal anti-inflammatory drug (NSAID) for the treatment of mild to ...
BERWYN, Pa.--(BUSINESS WIRE)--Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic ...
PALM SPRINGS, CA — Diclofenac, a commonly prescribed nonsteroidal anti-inflammatory drug (NSAID), was shown to provide acute pain relief when administered as a nanoformulated, lower-dose formulation, ...
CAMBRIDGE, Mass. -- Javelin Pharmaceuticals announced at its annual analyst and institutional investor day that its US product candidate Dyloject(R) (diclofenac sodium solution for injection) ...
Background: NSAIDs are widely used for patients presenting with low back pain. A quick-release formulation of lornoxicam, a potent NSAID from the chemical class of oxicams, offers a faster onset of ...
• Diclofenac is a non-steroidal anti-inflammatory drug (NSAID) which is used to treat mild-to-moderate pain, fever, and inflammation. • The recommended adult dose of diclofenac sodium or potassium is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback